The iFS Laser is currently used to create LASIK flaps and other corneal incisions. With the new clearance, the iFS Laser provides surgeons with the ability to make arcuate incisions during surgery.
“This is a major advancement and expansion of our femtosecond laser technology,” said Jim Mazzo, senior vice president, Abbott Medical Optics, in the release. “Abbott has been a pioneer in the ophthalmic use of femtosecond lasers, and this new use of our technology demonstrates our leadership position in this very dynamic and competitive market. This is an important step as we look to utilize femtosecond laser technology as a potential standard of care during the cataract procedure.”
Related Articles on FDA Clearances:
CurveBeam Receives FDA 510(k) Approval for the pedCAT 3D Foot and Ankle Scanner
Carestream Health Receives FDA Clearance for Mobile X-Ray System
Sotera Wireless Receives FDA 510(k) Clearance for ViSi Mobile Vital Signs Monitoring System
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.